Filtered By:
Condition: Chronic Obstructive Pulmonary
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 1666 results found since Jan 2013.
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Editorial More data on risks and outcomes of COVID-19 in asthma, COPD and bronchiectasis
Publication date: Available online 26 April 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Kian Fan Chung
Source: The Journal of Allergy and Clinical Immunology: In Practice - April 27, 2021 Category: Allergy & Immunology Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma
CONCLUSIONS: Hemopexin can be a novel biomarker with superior diagnostic ability in differentiating COPD and asthma. We propose an anti-inflammatory axis between the airways and systemic circulation, in which hemopexin is a protective component in airway disease.PMID:33733639 | PMC:PMC7984952 | DOI:10.4168/aair.2021.13.3.450
Source: Allergy, Asthma and Immunology Research - March 18, 2021 Category: Allergy & Immunology Authors: Natasha A Winter Peter G Gibson Michael Fricker Jodie L Simpson Peter A Wark Vanessa M McDonald Source Type: research
Clinical Presentation of Iranian Patients Affected with COVID-19: A Thousand Faces Disease
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):140-146.ABSTRACTThe coronavirus disease 2019 (COVID-19) pandemic in Iran is part of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study aimed to demonstrate the clinical characteristics of patients affected by COVID-19, in our tertiary teaching hospital. Medical records and compiled data of 668 patients with suspected COVID-19 were obtained retrospectively between January to April 2020. The present study outcomes included demographic features of infected patients, underlying diseases and conditions, the relationshi...
Source: Iranian Journal of Allergy, Asthma and Immunology - April 27, 2021 Category: Allergy & Immunology Authors: Ali Mostafaei Morteza Ghojazadeh Sakineh Hajebrahimi Nasrin Abolhasanpour Hanieh Salehi-Pourmehr Source Type: research
